The Effects of Dupilumab on Allergic Contact Dermatitis

Status Recruiting

Clinical Trial Summary

The aim of this study is to investigate the effects of dupilumab on allergic contact dermatitis.

Clinical Trial Description

The investigators will recruit 30 patients with allergic contact dermatitis who have not improved with allergen avoidance up to 18 months after patch testing, but where allergic contact dermatitis is still suspected. Subjects will receive 10 weeks of dupilumab, and both clinical data and tissue samples will be assessed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03935971
Study type	Interventional
Source	Brigham and Women's Hospital
Contact	Liset Chacin, BA
Phone	617-264-5926
Email	lchacin@bwh.harvard.edu
Status	Recruiting
Phase	Phase 4
Start date	December 18, 2019
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03945760` - Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects	Early Phase 1
Not yet recruiting	`NCT05498467` - The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis	Phase 3
Active, not recruiting	`NCT03680131` - Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis	Phase 2
Recruiting	`NCT05535738` - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation	Phase 2/Phase 3
Recruiting	`NCT06191627` - Patient Experience and Quality of Patch Testing on the Legs vs Back	N/A
Completed	`NCT00867607` - Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis	Phase 1/Phase 2
Recruiting	`NCT00445029` - Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation	N/A
Completed	`NCT04365140` - MicroRNA-126 and Its Target VCAM-1Dermatitis to Nickel
Recruiting	`NCT05991674` - A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques
Completed	`NCT00931242` - Study of Apremilast in Atopic or Contact Dermatitis	Phase 2
Completed	`NCT01798589` - Bioequivalence of Ethylenediamine Dihydrochloride Study	Phase 4
Completed	`NCT01546298` - Immune Reactions in Contact Dermatitis Affected Skin
Completed	`NCT05339750` - Allergy Skin Patch Artificial Intelligence (AI)	N/A
Completed	`NCT01797562` - Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents	N/A
Not yet recruiting	`NCT05858723` - Repeated Open Application Test (ROAT) Study With Hydroperoxides of Linalool	N/A
Completed	`NCT02534441` - Epidemiology and Co-Reactivity of Novel Surfactant Allergens	N/A
Not yet recruiting	`NCT01413477` - Nickel Desensitization Using Topical Therapy	N/A
Completed	`NCT00133341` - Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate	Phase 2
Completed	`NCT00132600` - Clinical Evaluation of Bacitracin	Phase 2
Completed	`NCT03902392` - Red Grape Polyphenol Oral Administration to Women Affected by Nickel-mediated Allergic Contact Dermatitis	N/A